Zymeworks Inc (ZYME)

Zymeworks (ZYME) Financial Statements


Zymeworks Financial Overview

Zymeworks's market cap is currently ―. The company's EPS TTM is $-1.789; its P/E ratio is -5.05; Zymeworks is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 10.03M$ 16.93M$ 16.51M$ 7.00M$ 35.58M
Gross Profit$ 10.03M$ 16.93M$ 16.51M$ 7.00M$ 35.58M
EBIT$ -37.80M$ -19.20M$ -27.58M$ -49.50M$ -22.96M
EBITDA$ -35.49M$ -15.86M$ -21.04M$ -44.98M$ -20.06M
Net Income Common Stockholders$ -31.65M$ -14.48M$ -28.69M$ -51.15M$ -24.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 345.05M$ 374.33M$ 295.41M$ 340.09M$ 340.79M
Total Assets$ 553.75M$ 580.88M$ 556.37M$ 602.05M$ 600.74M
Total Debt$ 25.13M$ 26.63M$ 26.25M$ 27.13M$ 27.22M
Net Debt$ -319.92M$ -347.70M$ -269.16M$ -312.96M$ -313.57M
Total Liabilities$ 115.75M$ 116.07M$ 132.02M$ 153.13M$ 127.20M
Stockholders Equity$ 438.00M$ 464.81M$ 424.34M$ 448.92M$ 473.54M
Cash Flow-
Free Cash Flow$ -38.32M$ 12.20M$ -43.80M$ -7.20M$ -84.08M
Operating Cash Flow$ -37.67M$ 13.95M$ -42.67M$ -6.40M$ -83.69M
Investing Cash Flow$ -7.32M$ -1.34M$ -7.02M$ -60.67M$ -137.72M
Financing Cash Flow$ 2.12M$ 50.61M$ 1.90M$ 27.60M$ 1.74M
Currency in USD

Zymeworks Earnings and Revenue History

Zymeworks Debt to Assets

Zymeworks Cash Flow

Zymeworks Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis